All Curated Mutation Sites in HIV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Keyword: HIV Infections-39552198

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	39552198	E138A	RT	gag-pol	HIV Infections	D G C L	View
2	39552198	E138G	RT	gag-pol	HIV Infections	D G C L	View
3	39552198	E138K	RT	gag-pol	HIV Infections	D G C L	View
4	39552198	F227L	RT	gag-pol	HIV Infections	D G C L	View
5	39552198	K101E	RT	gag-pol	HIV Infections	D G C L	View
6	39552198	K103N	RT	gag-pol	HIV Infections	D G C L	View
7	39552198	L10F	PR	gag-pol	HIV Infections	D G C L	View
8	39552198	L33F	PR	gag-pol	HIV Infections	D G C L	View
9	39552198	M184I	RT	gag-pol	HIV Infections	D G C L	View
10	39552198	M184V	RT	gag-pol	HIV Infections	D G C L	View
11	39552198	P225H	RT	gag-pol	HIV Infections	D G C L	View
12	39552198	Q58E	PR	gag-pol	HIV Infections	D G C L	View
13	39552198	S68G	RT	gag-pol	HIV Infections	D G C L	View
14	39552198	V106I	RT	gag-pol	HIV Infections	D G C L	View
15	39552198	V108I	RT	gag-pol	HIV Infections	D G C L	View
16	39552198	V179D	RT	gag-pol	HIV Infections	D G C L	View
17	39552198	V179E	RT	gag-pol	HIV Infections	D G C L	View
18	39552198	V179T	RT	gag-pol	HIV Infections	D G C L	View
19	39552198	Y181I	RT	gag-pol	HIV Infections	D G C L	View

Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.